Avecho Biotechnology Limited (OEZ) - Cash Flow Conversion Efficiency

Latest as of December 2022: -0.334x

Based on the latest financial reports, Avecho Biotechnology Limited (OEZ) has a cash flow conversion efficiency ratio of -0.334x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-808.80K ≈ $-945.58K USD) by net assets (€2.42 Million ≈ $2.83 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Avecho Biotechnology Limited - Cash Flow Conversion Efficiency Trend (2013–2022)

This chart illustrates how Avecho Biotechnology Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Avecho Biotechnology Limited (OEZ) financial obligations for a breakdown of total debt and financial obligations.

Avecho Biotechnology Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Avecho Biotechnology Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Pursuit Minerals Ltd AU:PUR	-0.019x
Zantat Holdings Berhad KLSE:0301	0.023x
Smith Micro Software Inc NASDAQ:SMSI	-0.107x
Cyclerion Therapeutics Inc NASDAQ:CYCN	-0.174x
Orissa Bengal Carrier Limited NSE:OBCL	0.014x
Energous Corporation NASDAQ:WATT	-0.180x
Property Perfect Public Company Limited BK:PF	0.009x
RECYCLICO BATTERY METALS F:ID4	N/A

Annual Cash Flow Conversion Efficiency for Avecho Biotechnology Limited (2013–2022)

The table below shows the annual cash flow conversion efficiency of Avecho Biotechnology Limited from 2013 to 2022. For the full company profile with market capitalisation and key ratios, see OEZ market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2022-12-31	€2.42 Million ≈ $2.83 Million	€-1.67 Million ≈ $-1.95 Million	-0.687x	-0.54%
2021-12-31	€4.54 Million ≈ $5.30 Million	€-3.10 Million ≈ $-3.62 Million	-0.683x	-27.33%
2020-12-31	€2.65 Million ≈ $3.10 Million	€-1.42 Million ≈ $-1.66 Million	-0.536x	-316.76%
2019-12-31	€4.76 Million ≈ $5.56 Million	€1.18 Million ≈ $1.38 Million	0.247x	+144.12%
2018-12-31	€3.90 Million ≈ $4.56 Million	€-2.19 Million ≈ $-2.56 Million	-0.561x	+44.06%
2017-12-31	€6.40 Million ≈ $7.49 Million	€-6.42 Million ≈ $-7.51 Million	-1.003x	-82.13%
2016-12-31	€11.65 Million ≈ $13.62 Million	€-6.41 Million ≈ $-7.50 Million	-0.551x	-82.96%
2015-12-31	€28.93 Million ≈ $33.82 Million	€-8.71 Million ≈ $-10.18 Million	-0.301x	-118.93%
2014-12-31	€49.03 Million ≈ $57.32 Million	€-6.74 Million ≈ $-7.88 Million	-0.137x	+36.70%
2013-12-31	€39.50 Million ≈ $46.18 Million	€-8.58 Million ≈ $-10.03 Million	-0.217x	--

About Avecho Biotechnology Limited

F:OEZ Germany Biotechnology

Market Cap

$25.77 Million

€22.04 Million EUR

Market Cap Rank

#26309 Global

#2267 in Germany

Share Price

€0.01

Change (1 day)

+0.00%

52-Week Range

€0.00 - €0.01

All Time High

€0.03